Scientists in England are reporting what could be a significant breakthrough in the treatment of all forms of cancer stating that their research that suggests that cannabis’ psychoactive component, known as tetrahydrocannabinol (THC), could act to shrink cancerous tumors in patients stricken with the deadly disease.
Researchers from the University of East Anglia, in the UK, have found that THC appears to effect two receptors found in cancer tumors called cannabinoid receptors helping to shrink the deadly growths.
The scientists bombarded human cancer cells in mice with doses of THC that were isolated into compounds for the research study. The compounds were found by the researchers to help shrink tumors. The scientists hope that their discovery can lead to the development of a synthetic form of the compound that can eventually provide relief for patients who have been diagnosed with cancer.
The UK researcher’s discovery supports the opinion of the US medical Establishment. Although medical researchers and the community of cancer patients in the US are laboring under an embargo on researching the possible medical benefits of cannabis that is coordinated by politicians and the scientists who are beholden to them, the nation’s medical researchers from the National Institutes of Health reported in July of 2012 that the “evidence accumulated during the last decade supports that cannabinoids, the active components of Cannabis sativa and their derivatives, possess anticancer activity.”
The scientists cautioned that the cannabinol compound that has the diminishing effect on cancer tumors was specially synthesized for the experiments and was targeted directly at the cancerous tumors in specific concentrations – a medical application that cannot be achieved by cancer patients by self-administering cannabis using common methods of cannabis ingestion.